https://www.worldpharmatoday.com/news/ec-approves-celltrions-steqeyma-a-biosimilar-to-stelara-for-the-treatment-of-multiple-chronic-inflammatory-diseases/
EC approves Celltrion's SteQeyma, a biosimilar to Stelara for the treatment of multiple chronic...
Aug 27, 2024 - The European Commission (EC) approval is based on the totality of evidence including the results from a Phase III study in adults with moderate to severe...
for theecapprovessteqeymabiosimilar
https://www.biosim.es/autoadministrable/steqeyma/
STEQEYMA | BioSim
steqeyma